• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

分子標的治療の臨床応用へのアプローチ

Research Project

Project/Area Number 09255104
Research Category

Grant-in-Aid for Scientific Research on Priority Areas (A)

Allocation TypeSingle-year Grants
Research InstitutionNagoya City University

Principal Investigator

上田 龍三  名古屋市立大学, 医学部, 教授 (20142169)

Co-Investigator(Kenkyū-buntansha) 真弓 忠範  大阪大学, 大学院・薬学研究科, 教授 (00098485)
遠藤 啓吾  群馬大学, 医学部, 教授 (10115800)
山口 俊晴  京都府立医科大学, 助教授 (90111327)
大野 竜三  浜松医科大学, 教授 (70093002)
花井 陳雄  協和醗酵, 東京研究所, 主任研究員
Project Period (FY) 1997 – 1999
Project Status Completed (Fiscal Year 1999)
Budget Amount *help
¥111,000,000 (Direct Cost: ¥111,000,000)
Fiscal Year 1999: ¥37,000,000 (Direct Cost: ¥37,000,000)
Fiscal Year 1998: ¥37,000,000 (Direct Cost: ¥37,000,000)
Fiscal Year 1997: ¥37,000,000 (Direct Cost: ¥37,000,000)
Keywords分子標的 / 抗体療法 / 分子誘導療法 / 癌組織血管 / 糖鎖抗原GM2,GD2 / ヒト化抗体 / チオレドキシン / サロゲイトマーカー / RI標識抗体結合物 / GVHD予防 / 分化誘導療法 / 新規分子標的 / Surrogateマーカー / 癌組織血管内皮細胞 / モノクローナル抗体 / ミサイル療法 / キメラ抗体 / 微少残存腫瘍(MRD) / ADF
Research Abstract

本課題では現実に臨床応用の可能性が高まってきた抗体療法、分化誘導療法の研究を推進すると共に、がん化学療法における薬剤耐性および感受性からレドックス制御系、シグナル伝達系をとりあげ研究を行った。
1.抗体療法に関して
1)癌組織血管内皮細胞に対するモノクローナル抗体(TES-23)の作製に成功し、がん組織血管を標的にするミサイル療法の可能性が進展した(真弓)。2)糖鎖抗原には腫瘍特異性が有り、抗GD2抗体がアポトーシスを誘発すること(上田)、ヒト化糖鎖抗体の作製に成功し、GD3とIL-2融合抗体はマウス腫瘍の転移を顕著に抑制(花井)し、糖鎖抗原が癌治療の標的となることを明らかにした。3)臨床応用では、造血幹細胞移植におけるCD10,CD6抗体によるpurging効果の第1,2相研究(上田)。I-131で標識した抗CD20抗体(遠藤)、カリキアマイシン結合ヒト化抗CD33抗体(CMA-676)(大野)の前臨床研究、大腸癌に対するキメラ抗体と抗癌剤複合体(chA7-NCS)の第1相試験(山口)が施行された。
2.分化誘導療法に関しては、deoxycoformycin と deoxyadenosineおよびその誘導体の併用により単球性白血病細胞にアポトーシスを誘導し、in vivoで併用効果を認めた(本間)。臨床的には分化誘導剤(ATRA)耐性のAPL白血病に対して、新規分化誘導剤Am80の有効性を実証した。
3.化学療法剤の新規分子標的に関しては、1)チオレドキシンの結合蛋白質(TBP-2)を同定し、TBP-2がチオレドキシンの活性を負に制御することや、HTLV-Iによる細胞のトランスフォーメーションへの関心を明らかにした。(淀井)。
2)Cytostatic薬(UCN-01、E7070、YTA0040)の抗腫瘍効果に関わるsurrogateマーカーともなるべき標的分子を同定した(西條)。

Report

(3 results)
  • 1999 Annual Research Report
  • 1998 Annual Research Report
  • 1997 Annual Research Report
  • Research Products

    (103 results)

All Other

All Publications (103 results)

  • [Publications] Ueda, R.: "How can we predict and prevent the occurrence of therapy-related leukemias?"Jpn. J. Clin. Oncol.. 29・1. 1-2 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Kato, T.: "Amino acid substitutions in NS5A region of GB virus C and response to interferon therapy"J. Med. Virol.. 57. 376-382 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Ohba, K.: "Seroprevalence of hepatitis B virus, hepatitis C virus and GB virus-C infections in Siberia"Epidemiology Infection. 122. 139-144 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Ueda, R.: "Clinical application of molecular diagnosis for cancer patients : Symposium on present stayus of clinical oncology"Int. Medicine. 38・2. 183-186 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Nitta, M.: "Multiple myeloma preceding the development of chronic myelogenous leukemia"Int. J. Hematol. 69. 170-173 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Sato, Y.: "Association of cyclin D1 expression with factors correlated with tumor progression in human hepatocellular carcinoma"J. Gastroenterol. 34. 1-8 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Saito, H.: "Challenges in Cancer Metastasis"Cancer Chenotherapy and Pharmacology. 43. S1-S2 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Mizokami, M.: "Mutation patterns for two flaviviruses: hepatitis C virus and GB virus C/hepatitis G virus"FEBS Letters. 450. 294-298 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Inagaki, H.: "Prognostic significance of CD44v6 in diffuse large b-cell lymphoma"Modem Pathology. 12・5. 547-552 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Kiyoi, H.: "Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia"Blood. 93. 3074-3080 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Iida, S.: "Chromosomal rearrangement of the PAX-5 locus in lymphoplasmacytic lymphoma with t(9;14)(p13;q32)"Leukemia and Lymphoma. 34・1-2. 25-33 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Kato, H.: "High prevalence and phylogenetic analysis of TT-virus infection in Mongolia"Virus Res.. 60. 171-179 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Cao, K.: "TT virus infection among IVDUs in south western China"Scand J. Infect. Dis. 31. 21-25 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Kato, T.: "High prevalance of TT virus infection in Japanese patients with liver diseases and in blood donors"J. Hepatol.. 31. 221-227 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Kondo, T.: "Microsatellite instability associated with hepatocarcinogenesis"J. Hepatol. 31. 529-536 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Kikuchi, M.: "Concurrent existence of antitopoisomerase I and anticentromere antibodies"厚生院紀要. 25. 29-40 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Miyawaki, S.: "Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy. The Japan Adult Leukemia Study Group"Int. J. Hematol. 70. 56-57 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Ding, X.: "Prevalence of TT virus and GBV-C infections among patients with liver diseases and the general population in Shanghai, China"Virus Genes. 19. 51-58 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Harada, S.: "Molecular and immunological dissection of diffuse large B cell lymphoma : CD5+, and CD5- with CD10^+ groups may constitute clinically relevant subtypes"Leukemia. 19. 51-58 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Yoshida, S.: "Detection of MUM1/IRF4-IgH fusion in multiple myeloma"Leukemia. 13. 1441-1447 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Niimi, T.: "Vitamin D receptor gene polymorphism in patients with sarcoidosis"Am. J. Respir. Crit. Care Med.. 160. 1107-1109 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Yoshinouchi, T.: "Myofibroblasts and S-100 protein positive cells in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated interstitial pneumonia"Eur. Respir J.. 14. 579-584 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Kato, T.: "Development of a TT virus DNA quantification system using real-time detection PCR"J. Clnical Microbiol.. 38・1. 94-98 (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] Mori, T.: "Aberrant overexpression of 53BP2 mRNA in luug cancer cell lines"FEBS Letters. 425. 124-128 (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] Zhao, M.: "In vivo treatment of mutant FLT3-transformed murine leukemia with a tyrosine kinase inhibitor"Leukemia. (in press). (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] Iida, S.: "Detection of MUM1/IRF4-LgH fusion in multiple myeloma"Leukemia. (in press). (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] Takeyama, T.: "Therapy-related leukemia and myelodysplastic syndrome: a large-scale Japanese study of clinical and cytogenetic features as well as prognostic factors"Int. J. Hematol.. ( in press). (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] Sao,H.: "A new marrow T cell depletion method using anti-CD6 monoclonal antibody conjugated magnetic beads,and its clinical application for prevention of acute graft-versus-host disease in allogeneic bone marrow transplatation-the results of phase I-II trial." Int.J.Hematol.(in press)

    • Related Report
      1998 Annual Research Report
  • [Publications] Nakayama,M.: "Hypometholation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias." Blood. 92(11). 4296-4307 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Ni,H.: "Detection of fusion transcripts by semiquantitative multiplex RT-PCR combined with a colormetric assay in Ph positive leukemia." Cancer Letters. 124. 174-180 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Yamaguchi,T.: "Changes in expression of the antigen recognized by monoclonal antibody A7 in human pancreatic carcinoma cells." Cancer Letters. 126. 165-172 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Oriuchi,N.: "Antibody-dependent difference in biodistribution of monoclonal antibodies in animal models and humans." Cancer Immunol.Immunother. 46. 311-317 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Inoue,T.: "Biodistribution studies on 1-3-[fluorine-18] fluoro-α-methyl tyrosine : A potential tumor-detecting agent." J.Nucl.Med.39. 663-667 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Higuchi,T.: "Technetium-99m labeled chimeric human/mouse antigranulocyte antibody bone marrow scintigraphy : Preliminary clinical study." Nucl.Med.Commun.19. 463-474 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Ohizumi,I.: "Monoclonal antibodies recognize antigens expressed on rat tumor vasculature." Int.J.Cancer. 77. 561-566 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Kaneda,Y.: "Antitumor activity of tumor necrosis factor-α conjugated with diviny ether and maleic anhydride copolymer on solid tumors in mice." Cancer Res.58. 290-295 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Catimel,B.: "Direct immobilization of gangliosides onto gold-carboxymethyldextran sensor surfaces by hydrophobic interaction : applications to antibody characterization." Glycobioloby. 8. 927-938 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Takeuchi,M.: "Relapsed acute promyelocytic leukemia previously treated with all-trans retionic acid : clinical experience with a new synthetic retinoid,am-80." Leukemia and Lymphoma. (in press).

    • Related Report
      1998 Annual Research Report
  • [Publications] Zhang, W.: "The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms." Leukemia. 12. 1383-1391 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Makishima,M.: "Induction of differentiation in acute promyelocytic leukemia cells by 9-cis retionic acid α-tocopherol ester (9-cis tretinoine tocopheril)." Blood. 91. 4715-4726 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Ohnishi,K.: "Modulation of homeobox B6 and B9 genes expression in human leukemia cell lines during myelomonocytic differentiation" Leuk Lymphoma. 12. 1383-1391 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Mizuguchi,H.: "Tumor necrosis factor alpha-mediated tumor regression by the in vivo transfer of genes in-to the artery that leads to tumors" Cancer Res.(in press).

    • Related Report
      1998 Annual Research Report
  • [Publications] Niitsu,N.: "Human monocytoid leukemia cells are highly sensitive to apoptosis induced by 2'-deoxycoformycin and 2'-deoxyaden osine : Association with dATP-dependent activation of caspase-3." Blood. 92. 3368-3375 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Kanatani,Y.: "A novel uracil analog, 6-chloro-5-(2-propenyl)uracil preferentially enhances growth inhibition and differentiation of myeloid leukemia cells induced by 1α,25 dihydroxyvitamin D3." Exp.Hematol.26. 198-206 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Yokoyama,A.: "Evaluation by multivariate analysis of the differen-tiation inhibitory factor nm23 as a prognostic factor in acute myelogenous leukemia and application to other hematological malignancies." Blood. 91. 1845-1851 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Ueda,S.: "Redox regulation of caspase-3(-like)protease activity : Regulatory roles of thioredoxin and cytochromec." J.Immunol.161. 6689-6695 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Yoshida,M.: "Mechanism of antitumor action of PKC activator,gnidimacrin." Int.J.Cancer. 77. 243-250 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Hana,S.: "Adenovirus-mediated p16 gene transfer prevents drug-induced cell death through G1 arrest in human glioma cells." Int.J.Cancer. 77. 47-54 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Kasai,T.: "Factors that influence the eligibility of cancers for inclusion in clinical trials." Jpn.J.Clin.Oncol.28. 214-221 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Chen,Z.S.: "An active efflux system for heavy metals in cisplatin-resistant human KB carcinoma cells." Exp.Cell Res.240. 312-320 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Nishida,K.: "In vitro effects of a recombinant toxin,mSCF-PE40,targeting c-kit receptors ectopically expressed in small cell lung cancers" Cancer Letters. 113. 153-158 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Tanaka,K.: "Application of fluorescence in situ hybridization to detect residual leukemic cells with 9;22 and 15;17 translocations." Leukemia. 11. 436-440 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Yuasa,H.: "Case-control study of leukemia and diagnostic radiation exposure" Inter.J.Hematol.65. 251-261 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Ida,K.: "Detection of chimeric mRNAs by reverse transcriptase-polymerase chain reaction for diagnosis and monitoring of acute leukemias with 11q23 abnormalities" Medical and Pediatric Oncology. 28. 325-332 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Goi,K.: "DNA damage-associated dysregulation of the cell-cycle and apoptosis control in cells with germ-line p53 mutation." Cancer Res.57. 1895-1902 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Takeuchi,M.: "Re-induction of complete remission with a new synthetic retinoid,Am-80,for relapse of acute promyelocytic leukemia previously treated with all-trans retinoic acid" Brit.J.Haematol.97. 137-140 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Ogura,M.: "Phase I/II trial of cure-oriented high-dose chemoradiotherapy with transplantation of CD34^+ peripheral blood stem cells purified by the immunomagnetic bead method for refractory hematological malignancies" Cancer Chemother.Pharmaco. 40. S51-S57 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Kiyoi,H.: "Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocyti leukemia." Leukemia. 11. 1447-1452 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Tobita,T.: "Treatment with a new synthetic retinoid,am80,of acute promyelocytic leukemia relapso from complete remission induced by all-trans retinoic acid" Blood. 90.3. 967-973 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Suzuki,R.: "CD7^+ and CD56^+ myeloidd/natural killer cell precursor acute leukemia:a distinc hematolyphoid disease entity" Blood. 90.6. 2417-2428 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Hanamura,I.: "Idiopathic CD4^+ T-lymphocytopenia in a non-Hodgkin's lymphoma patient Internal Medicine" Int.Medicine. 36.9. 643-646 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Joh.T.: "Chimeric MLL products with a ras binding cytoplasmic protein AF6 involved in t(6;11)(q27;q23) leukemia localize in the nucleus" Oncogene. 15. 1681-1687 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Nishi,H.: "Reduced blood accumulation of biotinylated monoclonal antibody A7 after,the subsequent administration of avid in." Cancer Letters. 120. 127-134 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Kitamura,K.: "Chronologic changes in the clinicopathologic findings and survival of gastric cancer patients." J.Clin,Oncol.15. 3471-3480 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Otsuji,E.: "Decreased renal accumulation of biotinylated chimeric monoclonal antibody-neocarzinostatin conjugate after adeministration of avid in" Jpn.J.Cancer Res.88. 205-212 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Sakakura,C.: "Analysis of histological therapeutic effect,apoptosis rate and p53 status after combined treatmernt with radiation,hyperthermia and 5-fluorouracil suppositories for advanced rectal cancers" Brit.J.Cancer. 77. 159-166 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Kitamura,K.: "Early gastric cancer mimicfling advanced gastric cancer" Brit.J.Cancer. 75. 1769-1773 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Otsuji,E.: "End results of simultaneous pancreatectomy,splenectomy and total gastrectomy for patients with gastric carcinoma" Brit.J.Cancer. 75. 1219-1223 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Stabin,M.G.: "Radiation dosimetry for indium-111-pentetreotide." J.Nucl.Med.38. 1919-1920 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Hirano,T.: "Differentiating histologic malignancy of primary brain tumors:Pentavalent technetium-99r" J.Nucl.Med.38. 20-26 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Sakahara,H.: "Anti-murine anitibody response to mouse monoclonal antibodies in cancer patients." Jpn.J.Cancer Res.88. 895-899 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Ohizumi,I.: "Antibody-based therapy targeting tumor vascular endothelial cells suppresses solid tumor growth in rats." Biochem.Biophys.Res.Commun.232. 493-496 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Okada,N.: "Cytomedical therapy for IgG1 plasmacytosis in human interleukin-6 transgenic mice using hybridoma cells microencapsulated in alginate-poly(L) lysine-alginate membrane" Biochem.Biophys Res.Commun.1360. 53-63 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Tsutsumi,Y.: "PEGylation of interleukin-6 effectively increases its thrombopoietic potency" Thromb.Haemostas.77. 168-173 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Okada,N.: "Medical application of microencapsulating hybridoma cells in agarose microbeads "Cytomedicine",Therapeutic effect on IgG1 plasmacytosis and mesangioproliferative glomerrulonephritis in the interleukin-6 transgenic mouse." J.Control.Release. 44. 195-200 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Muzuguchi,H.: "Cytoplasmic gene expression system enhances the efficiency of cationic liposome-mediated in vivo gene transfer into mouse brain" Biochem.Biophys.Res.Commun.234. 15-18 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Igarashi,R.: "Lecithinaization of IL-6 enhances its thrombopoietic activity" J.Pharm.Pharmacol. 49. 113-118 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Teramoto,T.: "A novel type of calcium channel sensitive to w-agatoxin-TK in cultured rat cerebral cortical neurons" Brain Res.756. 225-230 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Okada,N.: "Immunological studies of SK2 hybridoma cells microencapsulated with alginate-poly(lysine-alginate(APA) membrane following allogeneic transplantation" Biochem.Biophys.Res.Commun.230. 524-527 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Tobita,T.: "Treatment with a new synthetic retinoid,Am80,of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid." Blood. 90.3. 967-973 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Asou,N.: "All-trans retinoic acid therapy for newly diagnosed acute promyelocytic leukemia." Cancer Chemother Pharmacol. 40. S30-S35 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Kitamura,K.: "Mutant AF-2 domain of PML-RAR α in retinoic acid-resistant NB4 cells:differentiation induced by RA is triggered directly through PML-RAR α and its down-regulation in acute promyelocytic leukemia." Leukemia. 11. 1950-1956 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Syinjo,K.: "Erythropoietin receptor expression on human bone marrow erythroid precursor cells by a newly-devised quantitative flow-cytometric assay" Brit.J.Haematology. 96. 551-558 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Miura,Y.: "Human urinary macrophage colony-stimulating factor reduces the incidence and durationof febrile neulropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia double-blind controlled study" J.Clin.Oncology. 15.8. 2954-2065 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Asou,N.: "All-trans retinoic acid therapy for newly diagnosed acute promyelocytic leukemia;comparison with intensive chemotherapy." Cancer Chemother Pharmacol. 10. S30-S35 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Miyoshi,H.: "Glucocorticoids induce apoptosis in acute myeloid leukemaia cell lines with at (8;21)chromosome translocation" Leukemia Res.21. 45-50 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Kasukabe,T.: "An anticancer derivative of butyric acid(pivalyloxymethy1 butyrate)and daunorubicin cooperatively prolongs surrival of of mice inoculated with monocytic leukemia cells" Brit.J.Cancer. 75. 850-854 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Kasukabe,T.: "Tra-1,a novel mRNA highly expressed in leukemogenic mouse mouse monocytic sublines but not in nonleukemogenis sublines" Blood. 89. 2975-2985 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Niitsu,N.: "Neplanocin A,a potent inhibitor of S-adenosylhomocysteine hydrolase,potentiates granulocytic differentiation of acute promyelocytic leukemia cells induced by all-trans retinoic acid" Exp.Hematol.25. 1296-1303 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Niitsu,N.: "AML1a,but not AML1b,inhibits erythroid defferentiation induced by sodium butyrate and enhances megakaryocytic differentiation of K562 leukemia cells" Cell Growth Differen.8. 319-326 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Hirota,K.: "AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1." Proc.Natl.Acad.Sci.USA. 94. 3633-3638 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Iwata,S.: "ATL-Derived Factor(ADF)/human thioredoxin prevents apoptosis of lymphoid cells induced by L-cystine and glutathione depletion. Possible involvement of Thiol-mediated redox regulation in apoptosis caused by pro-oxidant state." J.Immunol.158. 3108-3117 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Nakamura,H.: "Redox regulation of cellular activation" Annu.Rev.Immunol.15. 351-369 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Furuke,K.: "Role of intracellular redox status in apoptosis induction of HTLV-infected lymphocytes by retinoic acid." Cancer Res.57. 4916-4923 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Yamamoto,M.: "Induction of human thioredoxin in cultured human retinal pigment epithelial cells though cyclic AMP-dependent pathway:involvement in the cytoprotective activity of prostaglandin EI" Exp.Eye Res.65. 645-652 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Akamatsu,Y.: "Redox regulation of the DNA binding activity in transcription factor PEBP2:The roles of two concerved cysteine residues" J.Biol.Chemotherapy. 272. 14497-14500 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Ishida,T.: "Circumvention of glutathione-mediated mitomycin C-resistance by a mitomycin C analogue(KW-2149)." Int.J.Cancer. 72. 865-870 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Fukuoka,K.: "p16INK4 expression is associated with the increased sensitivity of human non-small cell lung cancer cells to DNA topoisomerase Winhibitors" Jpn.J.Cancer Res.88. 1009-1016 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Kurokawa,H.: "Effect of glutathione depletion on cisplatin resistance in cancer cells transfected with the & gamma;-glutamylcysteine synthetase gene" Jpn.J.Cancer Res.88. 108-110 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Kanzawa,F.: "Evaluation of synergism by a novel three-dimensional model for the combined action of cisplatin and etoposide on the growth of a human small-cell lung-cancer cell line,SBC-" Int.J.Cancer. 71. 311-319 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Kanzawa,F.: "In vitro interaction between gemcitabine and other anticancer drug suing a novel three-dimensional model" Semin.Oncol.24. S7-8-S7-16 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Arioka,H.: "In vitro and in vivo modulation by rhizoxin of non-p-glycoprotein-mediated vindesine resistance" J.Cancer Res.Clin.Oncol.123. 195-200 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Ogasawara,H.: "In vitro enhancement of a water-soluble duocarmycin-derivative,KW-2189 antitumor activity by caffeine-meiated DNA-repair inhibition in a human lung cancer cells" Jpn.J.Cancer Res.88. 1033-1037 (1997)

    • Related Report
      1997 Annual Research Report

URL: 

Published: 1997-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi